Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus

被引:60
|
作者
Chowdhary, V. R.
Grande, J. P.
Luthra, H. S.
David, C. S.
机构
[1] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Med, Div Rheumatol, Rochester, MN USA
[3] Mayo Clin, Coll Med, Div Lab Med & Pathol, Rochester, MN USA
关键词
pristane induced lupus; pulmonary vasculitis;
D O I
10.1093/rheumatology/kem117
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Pristane-induced lupus is a well-established model of murine lupus. Mice injected with Pristane develop lupus-specific autoantibodies and glomerulonephritis. A chance observation led us to identify and characterize haemorrhagic pulmonary capillaritis in Pristane-injected mice. Methods. Eight-week-old C57BI/10 (1310, H-2(b)) mice received a single intraperitoneal injection of 0.5 ml of Pristane. Control mice received phosphate-buffered saline (PBS) injection. Mice were bled at 2 weeks after Pristane injection and monthly thereafter for serology and for antinuclear antibody (ANA). To characterize pulmonary disease, bronchoalveolar lavage (BAL) was carried out for total and differential cell count. Cytokines levels were checked for IL-2, IL-4, TNF-alpha, IFN-gamma, IL-6 and IL-10. Lungs were examined by histopathology and electron microscopy. Results. All mice injected with Pristane developed a pulmonary capillaritis with perivascular infiltration with macrophages, neutrophils, lymphocytes and eosinophils. In addition, alveoli showed macrophage and neutrophil infiltration. The degree of perivascular and alveolar inflammation was moderate to severe. BAL was inflammatory with cell composition of macrophages, neutrophils, lymphocyte and eosinophils. There was evidence of endothelial injury on electron microscopy but no evidence of immune complex deposition. IL-6 and IL-1 0 were increased in BAL but levels of TNF-alpha, IFN-gamma, IL-2 and IL-4 were not. Anti-neutrophil cytoplasm antibody (ANCA) was negative. Kidneys demonstrated an increase in mesangial matrix and cellularity compatible with WHO Class 11 lupus lesion. There were immune complexes and complement deposition in the kidney. There were oil granulomas in peritoneum, spleen and liver but no evidence of vasculitis in these organs was seen. Conclusion. The relative ease and high penetrability of lesion makes it an attractive model to study pulmonary vasculitis.
引用
收藏
页码:1405 / 1410
页数:6
相关论文
共 50 条
  • [41] VITAMIN D TREATMENT ATTENUATED MUSCLE ATROPHY IN PRISTANE-INDUCED LUPUS MODEL
    Guaresi, Silvia
    dos Santos, Manuela
    de Souza Silva, Jordana Miranda
    Freitas, Eduarda Correa
    Busatto, Amanda
    do Espirito Santo, Rafaela Cavalheiro
    Monticielo, Odirlei
    Xavier, Ricardo Machado
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 51 - 51
  • [42] A novel monocyte differentiation pattern in pristane-induced lupus with diffuse alveolar hemorrhage
    Han, Shuhong
    Zhuang, Haoyang
    Arja, Rawad Daniel
    Reeves, Westley H.
    ELIFE, 2022, 11
  • [43] Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-Induced Lupus Model
    Tumurkhuu, Gantsetseg
    Chen, Shuang
    Montano, Erica N.
    Laguna, Duygu Ercan
    De los Santos, Gabriela
    Yu, Jeong Min
    Lane, Malcolm
    Yamashita, Michifumi
    Markman, Janet L.
    Blanco, Luz P.
    Kaplan, Mariana J.
    Shimada, Kenichi
    Crother, Timothy R.
    Ishimori, Mariko
    Wallace, Daniel J.
    Jefferies, Caroline A.
    Arditi, Moshe
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [44] Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation
    Leiss, H.
    Niederreiter, B.
    Bandur, T.
    Schwarzecker, B.
    Blueml, S.
    Steiner, G.
    Ulrich, W.
    Smolen, J. S.
    Stummvoll, G. H.
    LUPUS, 2013, 22 (08) : 778 - 792
  • [45] Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis
    Zhuang, Lili
    Luo, Xiaoqing
    Wu, Shufan
    Lin, Zhangmei
    Zhang, Yanan
    Zhai, Zeqing
    Yang, Fangyuan
    Li, Yehao
    Zhuang, Jian
    Luo, Guihu
    Xu, Wenchao
    He, Yi
    Sun, Erwei
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [46] cGAS deficiency enhances inflammasome activation in macrophages and inflammatory pathology in pristane-induced lupus
    Kumpunya, Sarinya
    Thim-uam, Arthid
    Thumarat, Chisanu
    Leelahavanichkul, Asada
    Kalpongnukul, Nuttiya
    Chantaravisoot, Naphat
    Pisitkun, Trairak
    Pisitkun, Prapaporn
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] CD22 expression is required for development of pristane-induced lupus model in mice
    Hamaguchi, Y.
    Matsushita, T.
    Hasegawa, M.
    Takehara, K.
    Tedder, T.
    Fujimoto, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S26 - S26
  • [48] ARTHRITIS IN A MODEL FOR SYSTEMIC LUPUS: INVOLVEMENT OF JOINTS, INNER ORGANS AND COURSE OF AUTOANTIBODIES IN PRISTANE-INDUCED LUPUS
    Leiss, H.
    Niederreiter, B.
    Bandur, T.
    Schwarzecker, B.
    Blueml, S.
    Steiner, G.
    Ulrich, W.
    Smolen, J.
    Stummvoll, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 824 - 824
  • [49] A novel NF-κB inhibitor, DHMEQ, ameliorates pristane-induced lupus in mice
    Qu, Huiqing
    Bian, Weihua
    Xu, Yanyan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (01) : 100 - 104
  • [50] EVALUATION OF IMMUNOMODULATORY EFFECTS OF MESENCHYMAL STEM CELL ON PRISTANE-INDUCED LUPUS MOUSE MODEL
    Hoseinzadeh, A.
    Yazdi, Z. Rezaei
    Arab, F. Lavi
    Mahmoudi, M.
    CYTOTHERAPY, 2021, 23 (05) : S71 - S71